Clinical Trials in Camberwell, Victoria
12 recruiting
Showing 1–12 of 12 trials
Recruiting
Phase 3
Efficacy and Safety of KAI-9531 Administered Once Weekly in Participants Living With Obesity or Overweight and Diabetes
Obesity With DiabetesOverweight With Diabetes
Kailera1,700 enrolled44 locationsNCT07284901
Recruiting
Phase 3
Efficacy and Safety of KAI-9531 Administered Once Weekly Compared With Semaglutide and Placebo in Participants Living With Obesity Who Do Not Have Diabetes
Obesity
Kailera1,200 enrolled32 locationsNCT07284979
Recruiting
Phase 3
A Clinical Study of Enlicitide in Participants With High Cholesterol (MK-0616-037)
Hyperlipidemia
Merck Sharp & Dohme LLC975 enrolled89 locationsNCT07216482
Recruiting
Phase 1
Trial to Evaluate Safety and Immune Response of an Investigational Pneumococcal Vaccine in Adults Aged 50 To 64 Years
Pneumonia, Bacterial
GlaxoSmithKline120 enrolled2 locationsNCT07428759
Recruiting
Phase 1Phase 2
Study of PRA-216 in Healthy Participants and Participants With Mild-to-Moderate Asthma
Mild to Moderate Asthma
Prana Therapies Inc96 enrolled7 locationsNCT07245368
Recruiting
Phase 3
Program to Assess Adverse Events and Change in Disease Activity of Oral Upadacitinib in Adult Participants With Moderate to Severe Systemic Lupus Erythematosus
Systemic Lupus Erythematosus
AbbVie1,000 enrolled369 locationsNCT05843643
Recruiting
Phase 1Phase 2
A Study to Evaluate Safety and Efficacy of OLX72021 in Healthy Males With Androgenetic Alopecia
Androgenetic alopecia (AGA)
Olix Pharmaceuticals, Inc.158 enrolled1 locationNCT07327359
Recruiting
Phase 1Phase 2
A Dose Escalation Study of IG3018 in Subjects With Hyperuricemia With or Without Chronic Kidney Disease
HyperuricemiaHypouricemia, Renal
Intelligem Therapeutics Australia Pty Ltd.60 enrolled6 locationsNCT06310967
Recruiting
Phase 2
Safety and Efficacy of ABP-745 in Participants With an Acute Gout Flare
Gout FlareAcute Gouty ArthritisGout Flares+1 more
Atom Therapeutics Co., Ltd380 enrolled38 locationsNCT07145229
Recruiting
Phase 1Phase 2
Safety and Immunogenicity of an Investigational Herpes Zoster Vaccine (Z-1018) Compared to Shingrix® in Healthy Adults 50 Years of Age and Over
vaccine preventable diseasesHerpes ZosterShingles
Dynavax Technologies Corporation764 enrolled13 locationsNCT06569823
Recruiting
Phase 1
A Study to Evaluate Safety, Reactogenicity, and Immunogenicity of the GSK 4-component Strep A Vaccine With Aluminum Hydroxide (Alum) or AS37 in Healthy Young Adults
Streptococcal Infections
GlaxoSmithKline108 enrolled2 locationsNCT07085702
Recruiting
Phase 2
A Study of Medical Cannabis Aerosol Via the Fixed-dose Syqe Inhaler as an Add-on Treatment of Diabetic Peripheral Neuropathic Pain (DPNP)
Syqe Medical192 enrolled38 locationsNCT06490445